论文信息 - Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models. - 字舞流文

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models.

K. Walsh | M. A. Evans | S. Sano | Ying Wang | K. Horitani | H. Ogawa | Heather Doviak | Yoshimitsu Yura | Miho Sano | Keita Horitani